We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PEB market cap is 68.96M. The company's latest EPS is NZD -0.0332 and P/E is -2.41.
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Revenue | 4.81M | 4.95M | 10.09M | 13.14M | 21.03M |
Operating Income | -18.23M | -19.1M | -14.54M | -20.51M | -32.04M |
Net Income | -17.92M | -18.89M | -14.22M | -19.79M | -26.97M |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Assets | 16.57M | 19.33M | 31.18M | 115.28M | 90.91M |
Total Liabilities | 2.66M | 4.82M | 6.08M | 6.91M | 8.15M |
Total Equity | 13.91M | 14.5M | 25.11M | 108.38M | 82.76M |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Operating | -17.51M | -15.39M | -13.57M | -17.55M | -25.58M |
Investing | 2.84M | -5.21M | -6.35M | -52.13M | 22.47M |
Financing | 14.29M | 17.65M | 22.21M | 100.66M | -1.28M |
Market Cap | 68.96M |
Price to Earnings Ratio | -2.41 |
Price to Sales Ratio | 3.09 |
Price to Cash Ratio | 0.83 |
Price to Book Ratio | 0.78 |
Dividend Yield | - |
Shares Outstanding | 811.27M |
Average Volume (1 week) | 29.23k |
Average Volume (1 Month) | 57.48k |
52 Week Change | -77.63% |
52 Week High | 0.38 |
52 Week Low | 0.07 |
Spread (Intraday) | 0.02 (21.82%) |
Company Name | Pacific Edge Limited |
Address |
anderson lloyd dunedin |
Website | https://www.pacificedge.co.nz |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions